AK2 Promotes the Migration and Invasion of Lung Adenocarcinoma by Activating TGF-β/Smad Pathway <i>In vitro</i> and <i>In vivo</i>.

导出 LinkOut

翻译打印收藏纠错

作者： Fangfang,Cai ^[1] ; Huangru,Xu ^[2] ; Daolong,Zha ^[1] ; Xiaoyang,Wang ^[1] ; Ping,Li ^[1] ; Shihui,Yu ^[1] ; Yingying,Yao ^[1] ; Xiaoyao,Chang ^[1] ; Jia,Chen ^[1] ; Yanyan,Lu ^[1] ; Zi-Chun,Hua ^[1] ; Hongqin,Zhuang ^[1]

作者单位： The State Key Laboratory of Pharmaceutical Biotechnology, College of Life Sciences, Nanjing University, Nanjing, China. ^[1] School of Biopharmacy, China Pharmaceutical University, Nanjing, China. ^[2] Changzhou High-Tech Research Institute of Nanjing University and Jiangsu TargetPharma Laboratories Inc., Changzhou, China. ^[3]

关键词 AK2 EMT TGF-β lung adenocarcinoma tumor metastasis

DOI 10.3389/fphar.2021.714365

PMID 34630090

发布时间 2021-10-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2021年12卷

714365页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

AK2 Promotes the Migration and Invasion of Lung Adenocarcinoma by Activating TGF-β/Smad Pathway <i>In vitro</i> and <i>In vivo</i>.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

AK2 Promotes the Migration and Invasion of Lung Adenocarcinoma by Activating TGF-β/Smad Pathway <i>In vitro</i> and <i>In vivo</i>.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除